Health Catalyst, Inc. Form 8-K Summary
Business Context and Reporting Period
Health Catalyst, Inc. (HCAT), a Delaware corporation, filed this Current Report on Form 8-K on November 12, 2019. The filing serves to announce the Company's financial results for the third quarter of 2019. The Company is an emerging growth company and its common stock trades on The Nasdaq Global Select Market.
Key Financial Metrics
This Form 8-K does not contain specific numerical data regarding revenue, profit, cash flow, margins, debt, or liquidity. The filing explicitly states that the financial results are detailed in a press release attached as Exhibit 99.1, which is incorporated by reference. Consequently, no specific financial metrics can be extracted from the text of this filing alone.
Material Changes
The filing does not provide specific details on material changes versus the prior comparable period. It references the attached press release for the full disclosure of third-quarter 2019 operational and financial performance.
Guidance, Outlook, and Risks
The text of this filing does not include management commentary, forward-looking guidance, specific risk factors, or contingencies. These elements are contained within the referenced press release (Exhibit 99.1). The filing notes that the information furnished is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated November 12, 2019) for actual Q3 2019 revenue, net income, and cash flow figures.
- Verify year-over-year growth rates and margin trends in the attached press release.
- Check for any updated full-year 2019 guidance provided in the press release.
- Confirm the status of the Company's emerging growth company election and its impact on financial reporting standards.